Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients (ESCAPE)

This study has been completed.
Sponsor:
Collaborators:
European Commission
Boehringer Ingelheim
Baxter Healthcare Corporation
Aventis Pharmaceuticals
Information provided by:
Heidelberg University
ClinicalTrials.gov Identifier:
NCT00221845
First received: September 15, 2005
Last updated: January 11, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
Publications: